Literature DB >> 25131594

Spontaneous self-assembly of pathogenic huntingtin exon 1 protein into amyloid structures.

Philipp Trepte1, Nadine Strempel1, Erich E Wanker1.   

Abstract

PolyQ (polyglutamine) diseases such as HD (Huntington's disease) or SCA1 (spinocerebellar ataxia type 1) are neurodegenerative disorders caused by abnormally elongated polyQ tracts in human proteins. PolyQ expansions promote misfolding and aggregation of disease-causing proteins, leading to the appearance of nuclear and cytoplasmic inclusion bodies in patient neurons. Several lines of experimental evidence indicate that this process is critical for disease pathogenesis. However, the molecular mechanisms underlying spontaneous polyQ-containing aggregate formation and the perturbation of neuronal processes are still largely unclear. The present chapter reviews the current literature regarding misfolding and aggregation of polyQ-containing disease proteins. We specifically focus on studies that have investigated the amyloidogenesis of polyQ-containing HTTex1 (huntingtin exon 1) fragments. These protein fragments are disease-relevant and play a critical role in HD pathogenesis. We outline potential mechanisms behind mutant HTTex1 aggregation and toxicity, as well as proteins and small molecules that can modify HTTex1 amyloidogenesis in vitro and in vivo. The potential implications of such studies for the development of novel therapeutic strategies are discussed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25131594     DOI: 10.1042/bse0560167

Source DB:  PubMed          Journal:  Essays Biochem        ISSN: 0071-1365            Impact factor:   8.000


  7 in total

Review 1.  Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities.

Authors:  Rachel J Harding; Yu-Feng Tong
Journal:  Acta Pharmacol Sin       Date:  2018-04-05       Impact factor: 6.150

2.  Delayed emergence of subdiffraction-sized mutant huntingtin fibrils following inclusion body formation.

Authors:  Steffen J Sahl; Lana Lau; Willianne I M Vonk; Lucien E Weiss; Judith Frydman; W E Moerner
Journal:  Q Rev Biophys       Date:  2015-09-09       Impact factor: 5.318

3.  The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington's disease patients.

Authors:  Andreas Neueder; Christian Landles; Rhia Ghosh; David Howland; Richard H Myers; Richard L M Faull; Sarah J Tabrizi; Gillian P Bates
Journal:  Sci Rep       Date:  2017-05-02       Impact factor: 4.379

Review 4.  How Do Post-Translational Modifications Influence the Pathomechanistic Landscape of Huntington's Disease? A Comprehensive Review.

Authors:  Beata Lontay; Andrea Kiss; László Virág; Krisztina Tar
Journal:  Int J Mol Sci       Date:  2020-06-16       Impact factor: 5.923

5.  Natural Genetic Variation in Yeast Reveals That NEDD4 Is a Conserved Modifier of Mutant Polyglutamine Aggregation.

Authors:  Theodore W Peters; Christopher S Nelson; Akos A Gerencser; Kathleen J Dumas; Brandon Tavshanjian; Kyu Chul Chang; Gordon J Lithgow; Robert E Hughes
Journal:  G3 (Bethesda)       Date:  2018-11-06       Impact factor: 3.154

Review 6.  Significant Association Between Huntingtin Gene Mutation and Prevalence of Hopelessness, Depression and Anxiety Symptoms.

Authors:  Adelė Butėnaitė; Robertas Strumila; Aistė Lengvenytė; Indrė Kotryna Pakutkaitė; Aušra Morkūnienė; Aušra Matulevičienė; Edgaras Dlugauskas; Algirdas Utkus
Journal:  Acta Med Litu       Date:  2021-01-21

Review 7.  Huntington's disease: nearly four decades of human molecular genetics.

Authors:  James F Gusella; Jong-Min Lee; Marcy E MacDonald
Journal:  Hum Mol Genet       Date:  2021-10-01       Impact factor: 5.121

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.